Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma

Virchows Archiv · Published 2026-07-13 · DOI 10.1007/s00428-026-04640-w

Authors (14)

Ruoyu Shi, Yimeng Sang, Christopher Ze Xin Chua, Liuxiao Yang, Jabed Iqbal, Priscilla Wen Xian Loh, Gaohua Wu, Rongkui Luo, Ye Xin Koh, Jia Fan, Qiang Gao, Hongping Xia, Jian Zhou, Kai Zhu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Shi, R., Sang, Y., Chua, C., et al. (2026). Immune-related pathologic response (irPR) features and immunotherapeutic response score (ITRS) predict survival following neoadjuvant/conversion combined immunotherapy in intrahepatic cholangiocarcinoma. Virchows Archiv. https://doi.org/10.1007/s00428-026-04640-w

Related articles